Collecting bone marrow and blood samples for research
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
Abramson Cancer Center at Penn Medicine · NCT01985919
This study is collecting bone marrow and blood samples from volunteers to help researchers learn more about cancer and other diseases.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Abramson Cancer Center at Penn Medicine (other) |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT01985919 on ClinicalTrials.gov |
What this trial studies
This protocol facilitates the collection of bone marrow aspirate/biopsy and blood specimens for research purposes, allowing subjects the option of sedation during the procedure. The samples will be banked for future research related to cancer and other diseases. The goal is to enhance the collection of research specimens that can support clinical research and improve understanding of various conditions.
Who should consider this trial
Good fit: Ideal candidates are individuals scheduled for a bone marrow aspirate or biopsy for research purposes.
Not a fit: Patients who do not require a bone marrow procedure or those with contraindications to sedation may not benefit from this study.
Why it matters
Potential benefit: If successful, this could lead to improved research capabilities and advancements in the understanding and treatment of cancer and other diseases.
How similar studies have performed: Other studies involving the collection of biospecimens for research have shown success, indicating that this approach is supported by prior research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Planned procedure including a bone marrow aspirate and/or bone marrow biopsy * The procedure is planned for the purpose of obtaining a research specimen (as part of another research study or as part of this stand-alone sample collection protocol.). Procedures with a dual purpose (i.e. to obtain both clinically-indicated specimens and research specimens) are permitted, but procedures to obtain clinical specimens only are not permitted. * All subjects must provide written informed consent for the biopsy procedure, the collection of bone marrow and blood specimens for research purposes and (if planned) the administration of sedation. Exclusion Criteria: * Moderate sedation may not be administrated to subjects with a clinical contraindication to its provision, or if the investigator believes that administration of moderate sedation would constitute under risk to the subject.
Where this trial is running
Philadelphia, Pennsylvania
- Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States (RECRUITING)
Study contacts
- Principal investigator: Dan Vogl, MD — Abramson Cancer Center
- Study coordinator: Dan Vogl, MD
- Email: PennCancerTrials@emergingmed.com
- Phone: 855-216-0098
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: No Restrictions on Diagnosis